Advertisement

Systemic Candidiasis

  • Laurie Anne Chu
  • Scott G. Filler

Abstract

Despite the widespread use of amphotericin B and azote antifungal agents, hematogenously disseminated infections caused by Candida species are a serious problem in hospitalized patients. Candida species continue to be the fourth most common cause of nosocomial septicemia, accounting for 5% to 10% of all nosocomial bloodstream infections. This incidence of candidemia surpasses the incidence of bacteremia caused by Escherechia coli or Klebsiella species. Furthermore, Candida species are the most common cause of deep-seated fungal infections in patients who have extensive burns or who have undergone orthotopic liver or bone marrow transplantation. In many cases, an indwelling vascular catheter is considered to be the portal of entry. In fact, Candida species are the third most common cause of catheter-related infections, causing 11% of these infections.

Keywords

Candida Albicans Candida Species Germ Tube Candida Glabrata Candida Parapsilosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wenzell RP: Nosocomial candidemia: risk factors and attributable motrality. Clin Infect Dis 1995, 20: 1531–1534.CrossRefGoogle Scholar
  2. 2.
    Bodey GP: Candidiasis: Pathogenesis, Diagnosis, and Treatment, 2nd Ed. New York: Raven Press; 1993.Google Scholar
  3. 3.
    Pfaller MA: Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996, 22 (suppl 2): S89 - S94.PubMedCrossRefGoogle Scholar
  4. 4.
    Rex JH, Pfaller MA, Barry AL, et al.: Antifungal suceptibility testing of isolates from a randomized multicenter trial of fluconazole vs. amphotericin B as therapy of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 1995, 39: 40–44.PubMedCrossRefGoogle Scholar
  5. 5.
    Wingard JR: Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995, 20: 115–125.PubMedCrossRefGoogle Scholar
  6. 6.
    Edwards JE: Candida species. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 4th Ed. Edited by Mandell GL, Bennett JH, Dolin R. New York: Churchill Livingstone; 1995: 2289–2306.Google Scholar
  7. 7.
    Crissey JT, Lang H, Parish LC: Manual of Medical Mycology. Woburn: Blackwell Science, 1995.Google Scholar
  8. 8.
    Odds FC, Bernaerts RIA: CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994, 32: 1923–1929.PubMedGoogle Scholar
  9. 9.
    Pfaller MA, Houston A, Coffman S: Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Canidida tropicales, Candida krusei and Candida (Torulopsis) glabrata. J Clin Microbiol 1996, 34: 58–61.Google Scholar
  10. 10.
    Thaler M, Pastakia B, Shawker TH, Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988, 108:88–100.Google Scholar
  11. 11.
    Clemente CD, ed.: Gray’s Anatomy, 30th ed. Philadelphia: Lea & Febiger; 1985.Google Scholar
  12. 12.
    Edwards JE Jr. Candida endophlhalmitis. In Current Clinical Topics in Infectious Diseases. Edited by Remington JS, Swartz MN. New York: McGraw-Hill; 1982: 386.Google Scholar
  13. 13.
    Fishman LS, Griffin JR, Sapico FL, Hecht R: Hematogenous Candida endophthalmitis: a complication of candidemia. N Engl J Med 1972, 286: 675–681.PubMedCrossRefGoogle Scholar
  14. 14.
    Herzog CA, Carson P, Michaud L, Asinger RW: Two-dimensional echocardiographic imaging of left ventricular vegetations. Am Heart J 1988, 115: 684–686.Google Scholar
  15. 15.
    Gallis HA, Sobel JD: Candiduria. In Atlas of Infectious Diseases, vol 9. Edited by Mandell GL, Sobel JD. Philadelphia: Current Medicine; 1997:5. 1–5. 15.Google Scholar
  16. 16.
    Kwon-Chung, KJ, Bennett JE: Candidiasis. In Medical Mycology. Philadelphia: Lea & Febiger; 1992: 280–336.Google Scholar
  17. 17.
    Uzun 0, Anaissie EJ: Problems and controversies in the management of hematogenous candidiasis. Clin Infect Dis 1996, 22 (suppl 2): S95–5101.PubMedGoogle Scholar
  18. 18.
    Edwards JE: International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 1997, 25: 43–59.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Laurie Anne Chu
  • Scott G. Filler

There are no affiliations available

Personalised recommendations